Using the 4 Pillars to Increase Vaccination Among High-Risk Adults: Who Benefits?
Pneumococcal; tetanus, diphtheria, and pertussis; and influenza vaccination increased among high-risk adults in a 2-year study.
Cost-Effectiveness of Pneumococcal and Influenza Vaccination Standing Order Programs
Improving influenza and pneumococcal vaccination rates through outpatient standing order programs, which allow vaccination without physician orders, is economically favorable in older Americans.
Economic Model for Emergency Use Authorization of Intravenous Peramivir
The US Food and Drug Administration granted emergency use authorization of intravenous neuraminidase inhibitors for patients with 2009 influenza A (H1N1), creating a need for economic studies.
Cost-Effectiveness of Pneumococcal Polysaccharide Vaccine Among Healthcare Workers During an Influenza Pandemic
Pneumococcal polysaccharide vaccination of healthcare workers during an influenza pandemic is cost-effective from a societal perspective but not from a hospital perspective without external subsidy.
Office Manager and Nurse Perspectives on Facilitators of Adult Immunization
Factors significantly associated with adult vaccination rates in primary care practices were patients’ age, race, scheduled well-visit length, and nurses’ vaccination status.
Relationship between Primary Payer and Use of Proactive Immunization Practices: A National Survey